Innovation Factors Toward Enhancing Organisation Performance : A Study On The Malaysian Healthcare Sector by Subramaniam, Nalini
  
INNOVATION FACTORS TOWARD ENHANCING 
ORGANISATION PERFORMANCE:  
A STUDY ON THE MALAYSIAN HEALTHCARE SECTOR 
NALINI A/P SUBRAMANIAM 
MASTER OF SCIENCE IN TECHNOLOGY MANAGAMENT  
2018      
 
 
 
 
INNOVATION FACTORS TOWARD ENHANCING ORGANISATION 
PERFORMANCE:A STUDY ON THE MALAYSIAN HEALTHCARE SECTOR 
 
 
 
 
 
 
NALINI A/P SUBRAMANIAM 
 
 
 
 
 
 
A thesis submitted 
in fulfillment of the requirements for the degree of Masters of Sceince in 
Technology Management 
 
 
 
 
 
 
 
 
Faculty of Technology Management and Technopreneurship 
 
 
 
 
 
 
 
 
 
 
UNIVERSITI TEKNIKAL MALAYSIA MELAKA 
 
 
 
 
 
 
2018 
 
 
 
 
DECLARATION 
 
 
I declare that this thesis entitled “Innovation Factors Toward Enhancing Organization 
Performance: A Study On Malaysian Healthcare Sector” is the result of my own 
research except as cited in the references. The thesis has not been accepted for any 
degree and is not concurrently submitted in candidature of any other degree. 
 
 
Signature :........................................... 
Name  :NALINI A/P SUBRAMANIAM 
Date   :.......................................... 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
APPROVAL 
 
 
 
I hereby declare that I have read this thesis and in my opinion this thesis is sufficient in terms of 
scope and quality for the award of Masters of Science in Technology Management. 
 
 
 
Signature                    :........................................................ 
Supervisor Name       :ASSOC.PROF DR.JUHAINI BINTI JABAR 
Date                            :........................................................ 
 
 
 
 
 
 
 
 
 
  
DEDICATION 
 
 
This thesis is dedicated to loving memory of my father and beloved mother who always loved me 
unconditionally and contastly give me support and encouragement throughout the process. 
Without their blessings and encouragement, this thesis impossible to complete. 
 
 
 
 
 
i 
 
 
 
ABSTRACT 
 
 
Healthcare sector one of the key economic driver and crucial sector in nation Gross Domestic 
Product (GDP) contribution. Healthcare sector in Malaysia consists with three main industries, 
Pharmaceutical, Medical device and Biotechnology. Malaysian government had segregates lumps 
of funds to evolve the healthcare industry in transition towards innovation economy by 2020. 
Currently Malaysian obtained capable infrastructure such as manufacturing plant and in house 
Research and Development (R&D). However, healthcare industry slow in modification and 
innovates business model which leads the healthcare industry left behind compare to other 
developing countries such as China and India. Moreover, most of major death caused in Malaysia 
were chronic diseases. Malaysia forced to export generic medicines from foreign market and 
government spend lump of funds on medicines and medical equipment export even on generic 
medicines. On the other side, Malaysia healthcare sector attract most of medical traveler with its 
traditional therapies and reasonable medical expenses. Malaysia have been as one of the medical 
hub in ASEAN countries, however the industry faces tough competition in terms of price and 
quality along with its neighbour countries. Recently a few scholar has has underlined factors that 
determined innovation in healthcare. However, there has limited empirical evidence proposing an 
innovation factors towards enhancing organization performance of healthcare in Malaysian 
context.  Therefore, more research needed to address the antecedents of innovation practice in 
order to boost up an organization performance in healthcare sector. Limited studies on innovation 
factors in healthcare sector in Malaysian context leads the path to researcher to overview on 
innovation factors which could boost the organization performance in terms of profit, sales, 
market share, and export rate, number of patents and global entry of the firm. Hence, Healthcare 
industry have capability to increase innovation to the next level and simultaneously enhance the 
contribution of gross domestic product and export activity. This study have identifies top 
management support, market orientation and research and development (R&D) alliance as an 
innovation factors which tested over organization performance of the healthcare industry. This 
study has attempted to analyze the innovation activities in healthcare industry in order to 
understand the factors leading to innovation towards enhancing organization performance. A 
research model has been developed and empirically tested through survey with 330 companies as 
a sample size. This study obtained data from 95 companies and were analyzed through logistics 
and multiple regression using SPSS. The result of this study indicated top management support as 
a most significant factor which influence organization performance in the context of healthcare 
industry in Malaysia.  
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ABSTRAK 
 
 
Sektor kesihatan adalah salah satu daripada pemacu ekonomi utama dan juga sektor penting 
dalam sumbangan negara Keluaran Dalam Negara Kasar (KDNK). Sektor kesihatan di 
Malaysia terdiri daripada tiga industri utama, Farmasi, Peranti perubatan dan 
Bioteknologi.Kerajaan Malaysia telah mengasingkan dana yang besar bagi industri kesihatan 
berkembang dalam peralihan ke arah ekonomi inovasi pada tahun 2020. Kini, industri kesihatan 
Malaysia memperolehi infrastruktur yang cekap seperti kilang pembuatan dan pusat 
Penyelidikan dan Pembangunan Walau bagaimanapun, industri kesihatan agak perlahan dalam 
pengubahsuaian dan memperbaharui model perniagaan yang menyebabkan industri kesihatan 
ketinggalan bandingkan dengan negara-negara membangun yang lain seperti China dan 
India. Selain itu, penyakit kronik adalah punca utama yang menyebabkan kematian di Malaysia. 
Malaysia terpaksa mengeksport ubat-ubatan generik daripada pasaran asing dan kerajaan 
membelanjakan wang yang besar untuk ubat-ubatan dan eksport peralatan perubatan biarpun 
ubat-ubatan generik. Di samping itu, sektor kesihatan di Malaysia menarik kebanyakan 
pelancong perubatan dengan adanya terapi tradisional dan perbelanjaan perubatan yang 
berpatutan. Malaysia telah dipilih sebagai salah satu pusat perubatan di antara  negara-negara 
ASEAN, bagaimanapun industri menghadapi persaingan sengit dari segi harga dan kualiti 
bersama dengan negara-negara jirannya. Baru-baru ini beberapa penyelidik telah 
menggariskan faktor-faktor yang menentukan inovasi dalam sektor kesihatan. Pada masa yang 
sama, bukti kajian sangat terhad dalam  mencadangkan satu faktor inovasi ke arah 
meningkatkan prestasi organisasi penjagaan kesihatan dalam konteks Malaysia. Oleh yang 
demikian, penyelidikan yang berlebihan diperlukan untuk mengetahui latar belakang amalan 
inovasi bagi meningkatkan prestasi organisasi dalam sektor penjagaan kesihatan. Kekurangan 
kajian terhadap faktor-faktor inovasi dalam sektor penjagaan kesihatan dalam konteks Malaysia 
dapat membuka laluan kepada penyelidik untuk mengkaji  faktor-faktor inovasi yang boleh 
meningkatkan prestasi organisasi dari segi keuntungan, jualan, saham pasaran, dan nilai 
eksport, bilangan paten dan juga penglibatan firma secara menyeluruh. Berikutan itu, industri 
kesihatan berkeupayaan untuk meningkatkan prestasi inovasi ke peringkat seterusnya dan pada 
masa yang sama meluaskan sumbangan Keluaran Dalam Negara Kasar (KDNK) dan usaha 
eksport. Dalam kajian ini, sokongan bahagian pengurusan atasan, orientasi pasaran dan 
perikatan penyelidikan dan pembangunan (R & D) telah dikenalpasti sebagai faktor inovasi yang 
dikaji ke atas prestasi organisasi industri kesihatan. Kajian ini dilaksanakan untuk menilai 
faktor-faktor yang mempengaruhi inovasi dan menganalisis aktiviti inovasi dalam industri 
kesihatan ke arah perkembangan prestasi organisasi. Kajian ini mewujudkan satu model analisis 
yang dikaji secara teliti dengan menggunakan 330 buah syarikat sebagai saiz sampel, sebaliknya 
data kajian ini diperoleh daripada 95 organisasi yang dianalisis melalui kaedah SPSS. Hasil 
kajian ini membuktikan bahawa bahagian pengurusan atasan adalah  faktor yang utama dan 
siknifikasi dalam mempengaruhi prestasi organisasi dalam konteks industri kesihatan di 
iii 
 
Malaysia. Tambahan pula, hasil kajian ini menyumbang maklumat baru ke atas keupayaan 
inovasi kesihatan serta mengimplikasi terhadap teori dan pengurusan. 
 
  
 
 ACKNOWLEDGEMENTS 
 
 
First and foremost, I would like to take this opportunity to express my sincere 
acknowledgement to my supervisor Professor Madya Dr. Juhaini binti Jabar from the 
Faculty of Technology Management and Technoprenuership, Universiti Teknikal 
Malaysia Melaka (UTeM) for her essential supervision, support and encouragement 
towards the completion of this thesis.  
 
I would also like to express my greatest gratitude to my co-supervisor Professor 
Madya Dr Norfaridatul Akmaliah Othman who gave me suggestions and helpful in 
the process to complete my thesis. Special thanks to UTeM PJP grant funding for the 
financial support throughout this project.  
 
Particularly, I would also like to express my deepest gratitude to Ms Kanagavalli 
who has always been as great friend throughout my journey and to all my 
postgraduate friends for sharing knowledge in statistical technique and has been 
great supported in the way to finish the analysis work 
 
Special thanks to all my peers, my late father, beloved mother, my fiance  
Mr.Vijayakumar and siblings for their moral support in completing this thesis. 
Lastly, thank you to everyone who had been to the crucial parts of realization of this 
work. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
iii 
 
1 
 
CHAPTER 1 
 
INTRODUCTION 
 
1.1 Project Introduction 
This chapter will present the theoretical research background and problem 
statement of the study. It also introduces the research questions and objectives. This is 
followed by the research scopes, research limitations, key assumptions of the project, 
importance of the project and the thesis layout. 
 
1.2 Background of the study 
The Malaysian government aims of achieving the status of a developed nation by 
2020. Therefore, efforts to attract Foreign Direct Investment (FDI), increase 
productivity, enhance innovation and promote R&D are crucial. For the Ninth Malaysian 
plan, the contribution of Total Factor Productivity (TFD) to Gross Domestic Product 
(GDP) growth increased by about 34.7% compared to 29.0 % during the Eighth 
Malaysia Plan (The Tenth Malaysia Plan 2011-2015). The ninth Malaysia plan intends 
to transform Malaysia into a high-income, knowledge-intensive and innovation-led 
economy. More often than not, the government’s role is to accelerate and enable 
emerging specialisations, especially through joint investment with the industry in terms 
of skills, guidance, Rsearch and Development (R&D) and facilitating infrastructure 
growth (The eleventh Malaysia Plan 2016-2020). Therefore, under the Evelenth 
Malaysian plan, the government will pay more attention to its resources and prioritise 
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specific national key economic areas (NKEAs) as part of the approach towards greater 
specialisation. A total of 12 main National Key Economic Areas (NKEA) have been 
listed down under the Economic Transformation Programme-A Roadmap for Malaysia. 
These NKEAs were selected based on their expected contribution to the Gross National 
Income (GNI) and growth opportunities in 2020. Among the 12 NKEAs, the healthcare 
sector one of the industries that is expected to assist Malaysia in achieving a high-
income status. The NKEA sectors shown below in figure 1.1 will evolve over time in the 
economy according to their performance growth.  
 
Figure 1.1: 12 main NKEA sectors in the Economic Transformation Programme, 2009 
 
 
T
he 
go
ve
rn
m
en
t 
se
es biotechnology as a key part of its efforts to industrialise and increase its knowledge-
based economy. Clinical research, infrastructure, promotion of generic drug exports and 
medical tourism are among the government’s strategies to develop the healthcare market 
through investment. Foreign investment in private healthcare facilities has also increased 
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as the country has expanded its role in the medical tourism market – with the number of 
medical tourists doubling from 2007–2012 (The Tenth Malaysia Plan 2011-2015). 
Malaysia given a top priority to healthcare sector with almost a dozen new 
projects worth about $300 million under the healthcare NKEA were announced by the 
Malaysian government in 2014. These projects include three new manufacturing plants, 
several foreign-domestic joint ventures and the expansion of a current production facility 
(The Tenth Malaysia Plan 2011-2015). Along with well-established infrastructure and 
good patent protection, Malaysia has also put in place a set of policies aimed to attract 
foreign healthcare companies to set up in-country facilities. Malaysia’s Science and 
Technology (S&T) Policy has highlighted the importance of the advancement of S&T as 
a tool for sustaining economic development and improving the quality of life and 
national security by 2020. The healthcare sector has been identified as an economically 
robust sector and a huge contributor to the nation’s Gross Domestic Product (GDP). 
According to the Malaysia Healthcare Travel Council (MHTC), the contribution by the 
healthcare industry to the GDP exceeded RM 1 billion in 2016.  Alternatively, medical 
tourism has captured the attention of other ASEAN countries towards Malaysia. 
Malaysia’s healthcare sector is thriving and essential to the Malaysian economy. 
Annually, 10% of the national budget is allocated to the development of the healthcare 
industry. Despite that, most researchers placed their attention on pharmaceutical and 
biotechnology industries. Therefore, the researcher is very keen to explore the healthcare 
industry and intends to identify the factors which lead to innovation activities and the 
enhancement of organisation performance.  
 
1.3 Problem Statement  
According to Frost and Sullivan (2016), Malaysia is well positioned to harness 
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opportunities in the healthcare services industry especially in areas such as primary care, 
specialty services, diagnostics services, medical tourism and aged care. The healthcare 
sector consists of three mainstream industries namely, pharmaceuticals, medical devices 
and biotechnology. The healthcare industry has been a key contributor for policy makers 
and the nation’s GDP. Through the Science, Technology and Innovation (STI) Policy, 
the government has allocated funds to drive the healthcare industry towards an 
innovation economy. Medical tourism is one of the subsectors which leads the 
healthcare industry with its quality service. The government’s aim to achieve the status 
of a developed nation also relies on the development of healthcare industries in the 
global market. Middle-income countries such as India and China are well known for 
their innovative capabilities in the medical sector. Both countries have acquired the 
latest medical technology and strong market capabilities. Besides that,  both countries 
have also received robust foreign direct investment for the medical sector. 
In a nutshell, the Malaysian government aims to facilitate generic export 
opportunities, medical manufacturers, export platforms, localisation and upgrading, as 
well as collaboration between MNCs and local manufacturers in order to develop the 
medical industry. It is also understood that innovative practices by the healthcare 
industry can have a drastic impact on the Gross Net Income (GNI) which may achieve 
RM 13.9 billion by the year 2020. The demand for healthcare services is  always 
growing worldwide. Far more high-quality healthcare services are needed, especially in 
emerging markets with dynamic growth. Developing countries also need substantial 
investments: three out of the eight United Nations Millennium Development Goals aim 
to enhance healthcare for large sections of the population. These goals can only be 
achieved by developing healthcare infrastructure on a sustainable basis, preferably in 
cooperation with private service-providers. To ensure sustainable and comprehensive 
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medical care, developing countries and emerging markets face great challenges. The 
government can join hands with the private sector in order to overcome these challenges. 
(Wieck et al., 2009) 
The Malaysian healthcare industry has room for development in terms of 
innovation capability and market capabilities.  For instance, Ramli and Taher (2008) 
stated that chronic diseases are the major cause of death and disability in Malaysia as 
they accounted for 71% of all deaths and 69% of the total number of diseases. 
Furthermore, Lee (2011) revealed that the healthcare industry has been slow in 
modifying and innovating its business model compared to other industries. According to 
the National Key Economic Areas (NKEA), the healthcare industry has been declared as 
an important sector for the economic layer. Moreover, Malaysia is one of the ASEAN 
countries which functions as a health hub and is prominent in the field of medical 
tourism (Lunt et al., 2011). Malaysia’s advantages in attracting medical tourists include 
good location, high quality services and cost-effective healthcare. Additionally, with the 
current international wave of interest for wellness and traditional therapies, Malaysia is 
able to attract travelers seeking affordable and high-quality treatment. Therefore, this 
study intends study the Malaysian healthcare sector and focus on the innovation stream 
as a resource gap which which has the potential to be developed in the healthcare sector. 
Enhancement in innovation capabilities can propel healthcare industries to another level. 
Innovation infusion can also improve organisation performance in term of sales, profit 
and market share. This study also emphasises that innovation does not stand alone 
without a competitive advantage. Competitive advantage is a vital source which makes 
the industry stand out in a global market. Healthcare industry development can lead to a 
positive impact on medical tourism as well. 
Studies of innovation in recent years, (Bers et al., 2009;  Naidoo, 2010;  
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Quintana-garcia, 2010;  Liu et al., 2011;  De Tienne and Mallette, 2012) have provided 
empirical evidence that innovation increases profits, new products in the market, 
sustainability in the economy, ecological and social development , export rates of 
products and the lifetime of firms in the market. In the Malaysian context, studies 
applying innovation in the supply chain (Lee, Lee, Schniederjans, 2011), six sigma 
applications in process innovation ( Khaidir and Habidin, 2014), supply chain 
management ( Alain, Chong, Chan, 2010) and also mindfulness-based strategies 
(Ndubisi, 2012) have been conducted. Furthermore, few scholars have underlined factors 
that determine innovation in the healthcare sector (Barei, Pen, Simoens, 2013 and 
Fatokun, Ibrahim & Hassali, 2013). However, there is limited empirical evidence 
proposing innovative factors towards enhancing organisation performance of the 
healthcare industry in the Malaysian context.  Therefore, more research is needed to 
address the antecedents of innovative practices in order to boost up  organisation 
performance in the healthcare sector. Limited studies on innovation factors in the 
healthcare sector in Malaysia led the researcher to review the innovation factors which 
could affect organisation performance in terms of profit, sales, market share, export rate 
and the number of patents. Thus, this study emphasises on innovation factors which lead 
to innovation and organisation performance. The metrics  of organisation performance 
include market share, sales and profit and the number of patents.  
1.4 Research Objectives 
This research intends to uncover the salient factors needed to encourage more 
efficient new product development processes in healthcare industries that will eventually  
lead to radical innovation research output. The findings of this study will be a basis for 
the healthcare industry to re-strategise the innovation process in order to achieve greater 
outcomes i.e. radical innovation, new products and commercialisation. The objectives of 
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this research are as follows: 
1. To investigate the innovation factors in the healthcare industry. 
2a. To analyse the relationship between innovation factors towards enhancing 
innovation in the healthcare sector. 
2b.   To analyse the relationship between innovation factors towards enhancing 
organisational performance in the healthcare sector. 
3.   To determine the most significant innovation factor for practising innovation and 
enhancing performance of the healthcare industry. 
1.5      Research Questions 
1. What are the innovation factors in the healthcare industry? 
2a. To what extent do innovation factors lead to the enhancement of innovation in the 
healthcare sector? 
2b. To what extent do innovation factors enhance the organisational performance of 
the healthcare industry? 
3. Which factor is most significant for innovative practices and performance 
enhancement of the healthcare industry? 
1.6 Research Scope 
The research scope focuses on identifying and analysing innovation factors which 
influence innovation and lead to organisational performance within Malaysian 
healthcare industries. In the context of NKEA, Malaysian healthcare industries consist of 
biotechnology, pharmaceuticals and medical devices. This research gauges the 
relationship between factors influencing innovation and performance growth in 
healthcare industries. Organisations which engaged in this study are companies 
furnished with pharmaceutical products and medical technology, as well as 
biotechnology firms with bio-nexus status within Malaysia. Overall, there are a few 
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categories of organisations involved in this research: public listed companies, 
multinational companies, local big companies, government-linked companies and small 
and medium enterprises. The sample sze derived in this study are from selected states in 
penisular of Malaysia.  
This section has discussed the scopes that are covered in this study. However, this 
study is not complete without its importance of the project. The next section will 
highlight the outcomes of the project.  
 
1.7       Importance of the project  
The key motive of this project is to identify the innovation factors vital for 
research and development of healthcare industries. Applying innovative practices in the  
healthcare industry will enable medical tourism to thrive and increase its 
competitiveness in the global market. Moreoever, the healthcare industry is one of the  
key drivers of a nation’s economy. The enhancement of organisation performance of 
healthcare industries tends to increase its contribution towards GDP growth in future. 
In terms of social impact, the use of innovation and technology can lead to 
healthy lifestyles among the community. In addition, the community will be able to 
enjoy generic medicine at reasonable prices. This research study can help highlight the 
importance of innovative ventures in the healthcare industry. In addition, Malaysian 
healthcare manufacturers as well as Research and Development (R&D) institutes can 
meet domestic health needs and contribute to global research efforts. Healthcare sector 
enhancement in performance will contribute good impact on export rates of medicines 
and medical devices to global market. Malaysian healthcare sector have bright and stong 
export market in middle estern countires with halal medicines. Moreover, Malaysia 
would be stong medical hub among the ASEAN Countries. 
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1.8      Definition of Terms 
In this study, several references and specialised terms have been identified as 
follows; 
Innovation is a complex process related to changes in production functions and 
processes whereby firms seek to acquire and build upon their distinctive technological 
competence. It is understood as a set of resources a firm possesses and the way in which 
these are transformed by innovative capabilities.  
The healthcare sector has been identified as one of the National Key Economic 
Area (NKEA) sectors which is gaining increasing attention from policy makers. In this 
study, the healthcare sector consists of three main industries namely, pharmaceuticals, 
medical devices (medical technology) and biotechnology. 
Organisation performance is an analysis of heathcare industry performance as a  
result of innovation factors (Top management, Market Orientation and Research & 
Development( R&D) alliances). Organisation performance measures the performance of  
firms through sales and profit, market entry and the number of patents.  
Resourced-based view categorises resources into four attributes: valuable, rare, 
unimitable and non-substitutable (VRIN). The resource-based view (RBV) is a 
managerial framework used to determine the strategic resources with the potential to 
deliver comparative advantage to a firm. These resources can be exploited by the firm in 
order to achieve sustainable competitive advantage. 
Top management Support in this study, the top management translates the policy 
(formulated by the board-of-directors) into goals, objectives, strategies and projects into 
a shared vision of the future. It makes decisions that affect everyone in the organisation, 
and is held entirely responsible for the success or failure of the enterprise. 
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Market orientation, this study utilised Narver and Slater (1990)’s market 
orientation elements namely, customer orientation, competitor orientation and inter-
functional coordination.  
Customer orientation as the first component requires understanding not only the 
current needs of the customer, but also the whole value network of the customer.  
Competitor orientation as the second MO component provides the firm with an 
opportunity to benchmark and compare, e.g. with alternative suppliers  
Interfunctional coordination relates to the involvement of personnel and other 
firm resources across the whole company in creating value for the customers and other 
stakeholders 
 
 
 
 1.9 Thesis Layout 
This thesis consists of six chapters. Each chapter is devoted to several major 
aspects of the study. 
Chapter 1 explains the background of the study, followed by a problem 
statement, research objectives, research scope, as well as research limitations. The final 
part of this chapter highlights the importance of the study.  
Chapter 2 summarises the research framework derived from the literature. The 
overview of manufacturing industries, Malaysian healthcare industries, the importance 
of innovation for the healthcare sector, factors which lead to innovation activities and 
organisation performance and the impact of organisation performance are presented. 
Chapter 3 illustrates the conceptual model, operationalisation variables and 
questionnaire construct in detail. This chapter presents the hypotheses that were tested in 
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chapter 5.  
Chapter 4 presents the research methodology of this study which includes 
sampling method, data collection, target respondents and finally a detailed explanation 
on the analysis methods used in the research.  
Chapter 5 discusses the descriptive analysis, Exploratory Factor Analysis, 
correlation, regression and logistic analysis. It also includes a detailed discussion and 
justification of the findings. 
Chapter 6 explains the research findings and presents the conclusion of this 
study. Finally, important implications such as implication theory and implication for 
managers and policy makers are explained, followed by the limitations and future 
direction of the study. 
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       CHAPTER 2 
 
         LITERATURE REVIEW 
 
2.1 Introduction 
This chapter gives an overview of the Malaysian economy and healthcare 
industries in Malaysia. This chapter intends to highlight how innovative practices evolve 
in developed and developing countries. In addition, this study identifies salient factors 
which result in positive impact towards organisation performance.  
 
2.2  Overview of Malaysian economy 
Since achieving independence in 1957, Malaysia has demonstrated stable 
improvement in its economy. Malaysia is a strategic location for investors to set up 
offshore manufacturing of advanced technological products for local and global markets. 
Malaysia offers investors a dynamic and vibrant business environment with the ideal 
fundamentals for growth and profits, supported by a market-oriented economy and pro-
business government policies. A well-developed infrastructure and productive workforce 
are Malaysia's key strengths. In addition, a nation which is politically stable with a well-
organised legal system provides incentives for investors to attempt good business deals. 
The presence of foreign manufacturers in Malaysia continuously demonstrates 
prospective economic growth through business expansion and diversification (The 
Malaysian Industrial Development Authority 2016).  
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Compared to other industrialised nations in ASEAN, Malaysia is considered as 
the most technologically developed country (The World Bank 2015).  The innovatively 
disposed economy of Malaysia is demonstrated through the nation's inclusion of a highly 
automated manufacturing sector, advanced electronics manufacturing, R&D, logistics, 
biotechnology, photonics, design, and innovation. The government's goal is likewise to 
make Malaysia a center point for other value chain exercises such as design and 
development (D&D), research and development (R&D), procurement, logistics, 
distribution and marketing, business support services and shared services. Malaysia 
achieved a Gross Domestic Profit (GDP) growth of about 4.5%- 5.5 % in 2015 (The 
Malaysian Industrial Development Authority, 2016).  
Understanding innovation in the manufacturing sector is important on several 
counts. First, despite its impressive growth and contribution to both GDP and 
employment, a lower productivity suggests deficiencies in both capital and human 
resource efficiencies. The extent in which innovation drives productivity should be a 
cause for concern. Second, any reliance on innovation to lift the economy from the 
“middle-income” status must include innovation in large and dominating manufacturing 
sectors (Narayanan and Hosseini, 2014).  
 
2.2.1  An overview of manufacturing industries 
Manufacturing sectors are closely integrated in a modern economy such that the 
competitiveness of manufacturing is crucially dependent on the productivity and 
efficiency of services (Narayanan and Hosseini, 2014). The manufacturing sector 
contributes largely to GDP growth, external trade and job creation. The manufacturing 
sector remains as a driving factor for the nation’s economic growth. A strong domestic- 
and export-oriented industry serves to accelerate the manufacturing sector. Malaysia's 
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economy increased by 4.5% in the final quarter of 2016 as it was reinforced by the 
manufacturing and service sector (Bank Negara Malaysia 2016).  In 2016, the GDP 
growth increased by about 4.2%. Table 2.1 shows Malaysia’s GDP growth between 
2015 and 2016. 
 
 
 
Table 2.1: Malaysia’s GDP Growth 
 
Sector Share 
2016 
(%) 
2015 2016 
Q4 Year Q3 Q4 Year 
Annual change (%) 
Service 54.2 5.0 5.1 6.1 5.5 5.6 
Manufacturing  23.0 5.0 4.9 4.2 4.8 4.4 
Mining  8.8 -1.3 4.2 3.0 4.9 2.7 
Agriculture 8.1 1.5 1.2 -6.1 -2.4 -5.1 
Construction  4.5 7.4 8.2 7.9 5.1 7.4 
GDP 98.6 4.5 5.0 4.3 4.5 4.2 
Source: Bank Negara Malaysia, 2016 
 
To capitalise on this continuous growth, the Economic Transformation 
Programme (ETP), domestic finance condition and strong inflows of foreign direct 
investment are expected to boost business opportunities in the manufacturing sector. 
The Malaysian manufacturing industry consists of eleven sectors namely, non-
metallic mineral industry, aerospace, textiles and textile products, basic metal products, 
electrical products, engineering support, food and sustainable resources, machinery and 
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equipment, medical devices, petrochemicals, and pharmaceuticals (Malaysian 
Investment Development Authority, 2016). According to Hipp and Grupp, (2005); 
Cunningham, (2007), Narayanan and Hosseini, (2014) innovation is defined and 
measured largely in the manufacturing sector. Thus, data on expenditures on R&D, the 
number of staff employed exclusively for R&D, the number of patents obtained, the 
introduction of new products, services or processes are considered evidence of 
innovative activities.  
 
2.3 Overview of healthcare industries in Malaysia 
The healthcare industry in Malaysia has became a powerful economic growth 
engine as a result of demographic change as well as greater prosperity and dynamic 
lifestyles. The healthcare industry in Malaysia has been growing rapidly and steadily 
since the beginning of the 90s. It has been identified as one of the National Key 
Economic Areas (NKEA) under the 10th Malaysia Plan (2011-2015). According to 
Hidayah Jamaludin et al ( 2013), healthcare in Malaysia has undergone radical 
transformation. Healthcare is a vital sector which will prove challenging to endure in 
this comprehensive economic climate (Khaidir et al., 2013). The booming healthcare 
industry has been supported by the government allocating RM23bn (US$5.2bn) for 
healthcare projects in 2016, which is approximately 10% of the annual budget 
(Economic Transformation Programme, ETP 2014). Moreover, healthcare is recognised 
as a fast growing industry which is one of the key drivers for economic growth.  
Medical tourism under the ETP has been flourishing, evolving and attracting 
foreign patients. Revenues from medical tourism are expected to achieve close to thirty 
percent by 2020 (ETP, 2014). Malaysia is well-positioned to attract medical travelers 
from China, India, Japan, the United Kingdom (UK) and the Middle East (Saudi Arabia 
